EUDA Health Holdings Limited (NASDAQ:EUDA) Sees Large Drop in Short Interest

EUDA Health Holdings Limited (NASDAQ:EUDA) saw a large decrease in short interest in the month of June. As of June 30th, there was short interest totaling 3,202 shares, a decrease of 38.7% from the June 15th total of 5,223 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average trading volume of 5,978 shares, the days-to-cover ratio is presently 0.5 days.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on EUDA shares. Zacks Research upgraded EUDA Health from a “strong sell” rating to a “hold” rating in a research report on Friday, May 8th. Weiss Ratings cut EUDA Health from a “sell (d)” rating to a “sell (e+)” rating in a report on Friday, May 8th. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $55.00.

Institutional Trading of EUDA Health

An institutional investor recently raised its position in EUDA Health stock. Citadel Advisors LLC grew its position in shares of EUDA Health Holdings Limited (NASDAQ:EUDA) by 57.7% during the third quarter, according to its most recent filing with the SEC. The firm owned 44,631 shares of the company’s stock after acquiring an additional 16,321 shares during the period. Citadel Advisors LLC owned about 0.12% of EUDA Health worth $78,000 at the end of the most recent quarter. Institutional investors and hedge funds own 4.35% of the company’s stock.

EUDA Health Stock Down 9.0%

EUDA Health stock traded down $1.18 during mid-day trading on Friday, reaching $11.91. 2,179 shares of the company traded hands, compared to its average volume of 3,101. The firm’s 50 day moving average price is $15.01 and its 200 day moving average price is $18.20. EUDA Health has a 52-week low of $5.26 and a 52-week high of $86.00.

EUDA Health (NASDAQ:EUDA) last issued its quarterly earnings data on Tuesday, May 5th. The company reported ($0.44) EPS for the quarter, topping the consensus estimate of ($1.20) by $0.76. The company had revenue of $1.92 million during the quarter, compared to the consensus estimate of $3.90 million. Research analysts anticipate that EUDA Health will post 1.6 EPS for the current year.

About EUDA Health

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.